Pediatric congenital heart disease (CHD) patients often undergo procedures involving ionizing radiation for diagnosis, treatment, and follow-up. Their cumulative radiation burden may increase their risk of late effects.
Purpose
To assess radiation exposures from cardiac catheterization and thoracic imaging in pediatric CHD patients, stratified by diagnosis, age, and imaging modality.
Material and Methods
Radiation exposure (cardiac catheterization, thoracic computed tomography [CT] and radiography) was retrospectively collected for individuals aged <18 years (born 2000–2020) with at least one catheterization for CHD. Cumulative effective dose (CED) was estimated per patient by diagnosis. Age-based variation in examination frequency and exposure was examined.
Results
A total of 1574 patients underwent 23,558 radiographic examinations. The most common diagnoses, atrial septal defect (ASD; 31% of the cohort) and patent ductus arteriosus (PDA; 30%), had a median CED of 2.3 and 2.9 mSv, respectively. The diagnoses resulting in highest CEDs were hypoplastic left heart syndrome (HLHS; 2.6%, 37.5 mSv), double inlet left ventricle (DILV; 2.4%, 48.4 mSv), and double outlet right ventricle (DORV; 2.6%, 31.3 mSv). Cardiac catheterization, thoracic CT, and radiography contributed 94%, 4%, and 2% of CED, respectively. Effective doses per patient for each diagnosis varied with age. Doses from cardiac catheterizations tended to be higher for patients exposed at ≤30 versus 31–90 months old.
Conclusion
Most patients with ASD and PDA had low CED and patients with HLHS, DILV, and DORV received ≥30 mSv. Patients with severe CHD often required early catheterization, which, in turn, led to higher effective doses in these patients due to larger conversion coefficients between dose area product/dose length product and effective dose in individuals aged ≤30 months.
HouyelLMeilhacSM. Heart development and congenital structural heart defects. Annu Rev Genomics Hum Genet2021;22:257–284.
2.
HoffmanJIEKaplanS. The incidence of congenital heart disease. J Am Coll Cardiol2002;39:1890–1900.
3.
LeirgulEFominaTBrodwallK, et al.Birth prevalence of congenital heart defects in Norway 1994–2009—a nationwide study. Am Heart J2014;168:956–964.
4.
Erikssen G, Liestøl K, Seem E, et al. Achievements in congenital heart defect surgery. Circulation 2015;131:337–346.
5.
Ait-AliLAndreassiMGFoffaI, et al.Cumulative patient effective dose and acute radiation-induced chromosomal DNA damage in children with congenital heart disease. Heart2010;96:269–274.
6.
GlatzACPurringtonKSKlingerA, et al.Cumulative exposure to medical radiation for children requiring surgery for congenital heart disease. J Pediatr2014;164:789–794.
7.
JonesTPBrennanPCRyanE. Cumulative effective and individual organ dose levels in paediatric patients undergoing multiple catheterisations for congenital heart disease. Radiat Prot Dosimetry2017;176:252–257.
8.
JohnsonJNHornikCPLiJS, et al.Cumulative radiation exposure and cancer risk estimation in children with heart disease. Circulation2014;130:161–167.
9.
McDonnellADowningTEZhuX, et al.Cumulative exposure to medical sources of ionizing radiation in the first year after pediatric heart transplantation. J Heart Lung Transplant2014;33:1126–1132.
10.
DowningTEMcDonnellAZhuX, et al.Cumulative medical radiation exposure throughout staged palliation of single ventricle congenital heart disease. Pediatr Cardiol2015;36:190–195.
11.
AfrozSØsteråsBHThevathasUS, et al. Use of ionizing radiation in a Norwegian cohort of children with congenital heart disease: imaging frequency and radiation dose for the Health Effects of Cardiac Fluoroscopy and Modern Radiotherapy in Pediatrics (HARMONIC) study. Pediatr Radiol2023;53:2502–2514.
12.
HillKDFrushDPHanBK, et al.Radiation safety in children with congenital and acquired heart disease: a scientific position statement on multimodality dose optimization from the image gently alliance. JACC Cardiovasc Imaging2017;10:797–818.
13.
HauptmannMByrnesGCardisE, et al.Brain cancer after radiation exposure from CT examinations of children and young adults: results from the EPI-CT cohort study. Lancet Oncol2023;24:45–53.
14.
Thierry-ChefITimmermannBJournyN, et al. Health effects of ionising radiation in paediatrics undergoing either cardiac fluoroscopy or modern radiotherapy (The HARMONIC project). EPJ Nucl Sci Technol2023;9:22.
15.
HarbronRWThierry-ChefIPearceMS, et al. The HARMONIC project: study design for assessment of cancer risks following cardiac fluoroscopy in childhood. J Radiol Prot2020;40:1074.
16.
El SayedMHRoushdyAMEl FarghalyH, et al. Radiation exposure in children during the current era of pediatric cardiac intervention. Pediatr Cardiol2012;33:27–35.
17.
OnnaschDSchröderFFischerG, et al.Diagnostic reference levels and effective dose in pediatric cardiac catheterization. Br J Radiol2007;80:177–185.
18.
GhelaniSJGlatzACDavidS, et al.Radiation dose benchmarks during cardiac catheterization for congenital heart disease in the United States. JACC Cardiovasc Interv2014;7:1060–1069.
19.
BorikSDevadasSMroczekD, et al.Achievable radiation reduction during pediatric cardiac catheterization: how low can we go?Catheter Cardiovasc Interv2015;86:841–848.
20.
BarnaouiSRehelJLBayssonH, et al.Local reference levels and organ doses from pediatric cardiac interventional procedures. Pediatr Cardiol2014;35:1037–1045.
21.
GlatzACPatelAZhuX, et al.Patient radiation exposure in a modern, large-volume, pediatric cardiac catheterization laboratory. Pediatr Cardiol2014;35:870–878.
22.
VergheseGRMcElhinneyDBStraussKJ, et al.Characterization of radiation exposure and effect of a radiation monitoring policy in a large volume pediatric cardiac catheterization lab. Catheter Cardiovasc Interv2012;79:294–301.
23.
SchmidtPWEDanceDRSkinnerCL, et al.Conversion factors for the estimation of effective dose in paediatric cardiac angiography. Phys Med Biol2000;45:3095.
24.
KarambatsakidouASahlgrenBHanssonB, et al.Effective dose conversion factors in paediatric interventional cardiology. Br J Radiol2009;82:748–755.
25.
DragusinOGewilligMDesmetW, et al.Radiation dose survey in a paediatric cardiac catheterisation laboratory equipped with flat-panel detectors. Radiat Prot Dosimetry2008;129:91–95.
26.
FranklinRCBélandMJColanSD, et al.Nomenclature for congenital and paediatric cardiac disease: the international paediatric and congenital cardiac code (IPCCC) and the eleventh iteration of the international classification of diseases (ICD-11). Cardiol Young2017;27:1872–1938.
27.
World Health Organization. International statistical classification of diseases and related health problems 10th revision; ICD-10 Version:2019. Geneva: WHO. Available at: https://icd.who.int/browse10/2019/en (accessed 11th April 2023)
28.
ICRP. The 2007 Recommendations of the International Commission on Radiological Protection. Ann ICRP2007;37:1–133.
29.
DeakPDSmalYKalenderWA. Multisection CT protocols: sex- and age-specific conversion factors used to determine effective dose from dose-length product. Radiology2010;257:158–166.
TapiovaaraMSiiskonenT. PCXMC, A Monte Carlo program for calculating patient doses in medical x-ray examinations. Report STUK -A231. 2nd ed. Helsinki: Finnish Centre for Radiation and Nuclear Safety, 2008.
32.
StataCorp. Stata statistical software: Release 17. College Station, TX: StataCorp LLC, 2021.
33.
HansenJHRungeUUebingA, et al.Cardiac catheterization and interventional procedures as part of staged surgical palliation for hypoplastic left heart syndrome. Congenit Heart Dis2012;7:565–574.
34.
RoeleveldPPAxelrodDMKlugmanD, et al.Hypoplastic left heart syndrome: from fetus to fontan. Cardiol Young2018;28:1275–1288.
35.
AndrewsRTullohR. Hypoplastic left heart syndrome: diagnosis and management. Hosp Med2002;63:24–27.
36.
Bell-CheddarYDevineWADiaz-CastrillonCE, et al.Double outlet right ventricle. Front Pediatr2023;11:1244558.
37.
VyasHHaglerDJ. Double inlet left ventricle. Curr Treat Options Cardiovasc Med2007;9:391–398.
WilkinsonJLAndersonRH. Anatomy of discordant atrioventricular connections. World J Pediatr Congenit Heart Surg2011;2:43–53.
40.
CheungYF. Congenital and paediatric acquired heart disease in practice. Singapore: Springer Nature,2023
41.
GarneE. Atrial and ventricular septal defects – epidemiology and spontaneous closure. J Matern Fetal Neonatal Med2006;19:271–276.
42.
CockerhamJTMartinTCGutierrezFR, et al.Spontaneous closure of secundum atrial septal defect in infants and young children. Am J Cardiol1983;52:1267–1271.
43.
SlaughterJLCuaCLNotestineJL, et al.Early prediction of spontaneous patent ductus arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation. BMC Pediatr2019;19:333.
44.
SemberovaJSircJMiletinJ, et al.Spontaneous closure of patent ductus arteriosus in infants ≤1500 g. Pediatrics2017;140:e20164258.
45.
De KlerkJCAEngbersAGJvan BeekF, et al.Spontaneous closure of the ductus arteriosus in preterm infants: a systematic review. Front Pediatr2020;8:541.
BennhagenRGMcLaughlinPBensonLN. Contemporary management of children with atrial septal defects. Am J Cardiovasc Drugs2001;1:445–453.
49.
SchneiderDJ. The patent ductus arteriosus in term infants, children, and adults. Semin Perinatol2012;36:146–153.
50.
BaruteauAEHascoëtSBaruteauJ, et al.Transcatheter closure of patent ductus arteriosus: past, present and future. Arch Cardiovasc Dis2014;107:122–132.
51.
CettaFBostonUSDearaniJA, et al.Double outlet right ventricle: opinions regarding management. Curr Treat Options Cardiovasc Med2005;7:385–390.
52.
SaleebSFJuraszekAGevaT. Anatomic, imaging, and clinical characteristics of double-inlet, double-outlet right ventricle. Am J Cardiol2010;105:542–549.
53.
RizkCFaresGVanhavereF, et al.Diagnostic reference levels, deterministic and stochastic risks in pediatric interventional cardiology procedures. Health Phys2020;118:185.
54.
SaremiFGeraAYen HoS, et al.CT and MR imaging of the pulmonary valve. RadioGraphics2014;34:51–71.
55.
GooHW. Double outlet right ventricle: in-depth anatomic review using three-dimensional cardiac CT data. Korean J Radiol2021;22:1894–1908.
56.
KumarPBhatiaM. Role of computed tomography in pre- and postoperative evaluation of a double-outlet right ventricle. J Cardiovasc Imaging2021;29:205–227.
57.
PriyaSNagpalPSharmaA, et al.Imaging spectrum of double-outlet right ventricle on multislice computed tomography. J Thorac Imaging2019;34:W89–W99.
58.
Bellsham-RevellH. Noninvasive imaging in interventional cardiology: hypoplastic left heart syndrome. Front Cardiovasc Med2021;8:637838.
KaraosmanogluADKhawajaRDAOnurMR, et al.CT and MRI of aortic coarctation: pre- and postsurgical findings. AJR Am J Roentgenol2015;204:W224–W233.
61.
NanceJWRingelREFishmanEK. Coarctation of the aorta in adolescents and adults: a review of clinical features and CT imaging. J Cardiovasc Comput Tomogr2016;10:1–12.
62.
DoshiARChikkabyrappaS. Coarctation of aorta in children. Cureus2018;10:e3690.
63.
DijkemaEJLeinerTGrotenhuisHB. Diagnosis, imaging and clinical management of aortic coarctation. Heart2017;103:1148–1155.
64.
BudoffMJShittuARoyS. Use of cardiovascular computed tomography in the diagnosis and management of coarctation of the aorta. J Thorac Cardiovasc Surg2013;146:229–232.
65.
MartinCJ. The application of effective dose to medical exposures. Radiat Prot Dosimetry2008;128:1–4.
66.
Peruzzo CornettoAAimonettoSPisanoF, et al.The contribution of interventional cardiology procedures to the population radiation dose in a ‘health-care level i’representative region. Radiat Prot Dosimetry2016;168:261–270.
67.
VanoESánchezRMJoséMF, et al.Conversion factors to estimate effective doses from kerma area product in interventional cardiology. Impact of added filtration. Phys Med2019;68:104–111.
68.
BozkurtABorD. Simultaneous determination of equivalent dose to organs and tissues of the patient and of the physician in interventional radiology using the Monte Carlo method. Phys Med Biol2006;52:317.
69.
JohnsonPBGeyerABorregoD, et al.The impact of anthropometric patient-phantom matching on organ dose: a hybrid phantom study for fluoroscopy guided interventions. Med Phys2011;38:1008–1017.
70.
KramerRKhouryHJVieiraJW. CALDose_X—a software tool for the assessment of organ and tissue absorbed doses, effective dose and cancer risks in diagnostic radiology. Phys Med Biol2008;53:6437.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
